|Main uses||Congenital sucrase-isomaltase deficiency (CSID)|
|Side effects||Abdominal pain, nausea, diarrhea, trouble sleeping, headache|
|Typical dose||2 ml with food|
Sacrosidase, sold under the brand name Sucraid, is a medication used to treat congenital sucrase-isomaltase deficiency (CSID). Use may also help support the diagnosis of the condition in question. It is taken by mouth each time a person eats.
Common side effects include abdominal pain, nausea, diarrhea, trouble sleeping, and headache. Other side effects may include allergic reactions. It replace the enzyme sucrase which assists in the breakdown of sugar (sucrose) into simpler forms.
It is taken at a dose of 17,000 units (2 ml) in those over 15 kg each time they eat.
Sacrosidase is dispensed as a clear solution, with a pale yellow tint, which has a sweet taste. Users must take with food and patients who take Sucraid can maintain a normal diet. Sucraid is packaged in two plastic bottles, each 118ml. A scoop to measure Sucraid is included within the package.
- "Sacrosidase". SPS - Specialist Pharmacy Service. 31 January 2017. Archived from the original on 9 October 2021. Retrieved 9 October 2021.
- "Sacrosidase Monograph for Professionals". Drugs.com. Archived from the original on 16 July 2017. Retrieved 9 October 2021.
- "Sucraid Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 9 October 2021.